Kane Biotech Inc. (TSXV:KNE)
Canada flag Canada · Delayed Price · Currency is CAD
0.0300
0.00 (0.00%)
Jun 10, 2026, 3:44 PM EST

Kane Biotech Revenue

Kane Biotech had revenue of 43.22K CAD in the quarter ending March 31, 2026, a decrease of -89.52%. This brings the company's revenue in the last twelve months to 58.57K, down -97.60% year-over-year. In the year 2025, Kane Biotech had annual revenue of 427.87K, down -79.44%.

Revenue (ttm)
58.57K
Revenue Growth
-97.60%
P/S Ratio
105.02
Revenue / Employee
n/a
Employees
n/a
Market Cap
6.15M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025427.87K-1.65M-79.44%
Dec 31, 20242.08M1.93M1,296.75%
Dec 31, 2023148.98K-2.52M-94.42%
Dec 31, 20222.67M1.06M65.96%
Dec 31, 20211.61M266.21K19.84%
Dec 31, 20201.34M-351.95K-20.78%
Dec 31, 20191.69M1.19M234.51%
Dec 31, 2018506.27K85.80K20.41%
Dec 31, 2017420.47K298.90K245.87%
Dec 31, 2015121.57K--
Dec 31, 2014---
Dec 31, 2013159.95K--
Dec 31, 2011---
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---
Dec 31, 2007---
Dec 31, 2006---
Dec 31, 2005---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition